Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $7,069,981 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,760,300 | $973,944 | 13.8% | $134.94 | +172.4% | Common | 91307C102 |
| ARGX | ARGENX SE | 1,238,467 | $761,657 | 10.8% | $186.36 | — | Sponsored ADR | 04016X101 |
| ASND | ASCENDIS PHARMA | 5,103,055 | $702,538 | 9.9% | $127.20 | — | Sponsored ADR | 04351P101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 2,029,000 | $626,089 | 8.9% | $138.83 | +102.6% | Common | 558868105 |
| KRYS | KRYSTAL BIOTECH INC | 2,628,822 | $411,831 | 5.8% | $86.03 | +106.2% | Common | 501147102 |
| APLS | APELLIS PHARMACEUTICALS INC. | 12,222,222 | $390,011 | 5.5% | $47.01 | -36.0% | Common | 03753U106 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,555,555 | $310,730 | 4.4% | $106.42 | +15.2% | Common | 803607100 |
| — | INTRA-CELLULAR THERAPIES INC | 3,050,000 | $254,736 | 3.6% | $70.93 | — | Common | 46116X101 |
| VERA | VERA THERAPEUTICS INC | 5,610,000 | $237,247 | 3.4% | $37.64 | +17.6% | Common | 92337R101 |
| XENE | XENON PHARMACEUTICALS INC | 5,666,666 | $222,133 | 3.1% | $18.87 | +119.1% | Common | 98420N105 |
| FOLD | AMICUS THERAPEUTICS INC. | 23,175,000 | $218,309 | 3.1% | $10.47 | -0.7% | Common | 03152W109 |
| RNAM | AVIDITY BIOSCIENCES INC | 7,500,000 | $218,100 | 3.1% | $22.34 | +87.1% | Common | 05370A108 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC. | 11,111,111 | $208,889 | 3.0% | $29.27 | -29.6% | Common | 04280A100 |
| KYMR | KYMERA THERAPEUTICS INC | 5,150,000 | $207,185 | 2.9% | $35.02 | +29.0% | Common | 501575104 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 2,770,100 | $150,001 | 2.1% | $35.93 | +42.1% | CLASS A ORD | 61559X104 |
| SLNO | SOLENO THERAPEUTICS INC | 2,525,000 | $113,499 | 1.6% | $40.48 | +28.0% | Common | 834203309 |
| — | BLUEPRINT MEDICINES CORP | 1,185,000 | $103,356 | 1.5% | $87.22 | — | Common | 09627Y109 |
| PCVX | VAXCYTE INC | 1,175,000 | $96,186 | 1.4% | $79.91 | +24.3% | Common | 92243G108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,462,500 | $96,130 | 1.4% | $85.96 | -22.1% | Common | 09061G101 |
| — | MERUS N V | 2,125,000 | $89,356 | 1.3% | $38.90 | — | Common | N5749R100 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 11,865,000 | $89,225 | 1.3% | $10.72 | -29.2% | Common | 09058V103 |
| ALKS | ALKERMES PLC | 2,450,000 | $70,462 | 1.0% | $28.75 | 0.0% | Common | G01767105 |
| OCUL | OCULAR THERAPEUTIX INC | 8,060,000 | $68,832 | 1.0% | $6.99 | +39.5% | Common | 67576A100 |
| MNKD | MANNKIND CORP | 8,750,000 | $56,263 | 0.8% | $3.56 | +88.6% | Common | 56400P706 |
| — | TOURMALINE BIO INC | 2,222,222 | $45,067 | 0.6% | $24.18 | — | Common | 89157D105 |
| QURE | UNIQURE NV | 2,175,000 | $38,411 | 0.5% | $8.63 | 0.0% | Common | N90064101 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 830,000 | $34,918 | 0.5% | $49.13 | +1.0% | Common | 90400D108 |
| TSHA | TAYSHA GENE THERAPIES INC | 19,999,999 | $34,600 | 0.5% | $2.04 | +1.7% | Common | 877619106 |
| — | 89BIO INC | 4,100,000 | $32,062 | 0.5% | $7.82 | — | Common | 282559103 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,345,000 | $30,154 | 0.4% | $14.44 | -48.0% | Common | 61225M102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,275,000 | $30,076 | 0.4% | $18.81 | -9.0% | Common | 87164F105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,500,000 | $25,900 | 0.4% | $14.36 | -35.5% | Common | 462260100 |
| SEPN | SEPTERNA INC | 1,110,000 | $25,419 | 0.4% | $23.65 | 0.0% | Common | 81734D104 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 9,910,642 | $23,290 | 0.3% | $6.38 | — | Sponsored ADR | 05280R100 |
| CGON | CG ONCOLOGY INC | 700,000 | $20,076 | 0.3% | $40.84 | -16.2% | Common | 156944100 |
| KURA | KURA ONCOLOGY INC | 2,250,000 | $19,598 | 0.3% | $22.49 | -36.0% | Common | 50127T109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,200,000 | $15,084 | 0.2% | $15.05 | 0.0% | Common | 77313F106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,651,982 | $9,631 | 0.1% | $9.99 | 0.0% | Common | 68062P106 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $8,990 | 0.1% | $24.27 | -90.7% | Common | 00032Q104 |